CooperSurgical

CooperSurgical has built one of the most comprehensive portfolios in women's health and fertility medicine, spanning devices, diagnostics, and assisted reproductive technology (ART) consumables used by clinicians across the globe.

A subsidiary of The Cooper Companies (NYSE: COO), CooperSurgical operates as the dedicated women's health division of a publicly traded corporation headquartered in San Ramon, California. The business focuses on two broad segments: fertility, covering the products and services that support IVF laboratories and ART procedures, and office and surgical, covering gynaecological instruments, uterine health devices, and contraception.

The fertility segment is particularly notable. CooperSurgical is widely recognised as a leading supplier to IVF clinics worldwide, offering ART consumables and media used throughout the embryology workflow, from oocyte handling through to embryo culture and transfer. This includes products from acquired brands such as Wallace, Origio, and The LifeGlobal Group, giving the company a broad reach across fertility laboratories in Europe, North America, Asia-Pacific, and beyond.

On the surgical and office side, the company supplies instruments and devices for endometrial assessment, minimally invasive gynaecological procedures, and intrauterine contraception, including the well-known PARAGARD copper IUD, which it markets in the United States.

CooperSurgical has grown substantially through acquisition, absorbing multiple specialist fertility and gynaecology businesses over the years. It serves healthcare providers ranging from large hospital systems to independent fertility clinics, positioning itself as a single-source partner for women's health product needs.

Further information is available at coopersurgical.com.